Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Veidekke: To continue refurbishment project in Stockholm

Veidekke's Swedish subsidiary Arcona has entered into an agreement with Genesta, a real estate fund management company, regarding the next phase of Zinko, a major refurbishment project at Södermalm, Stockholm. The collaborative design and build contract has a value of approximately SEK 336 million.The Zinko project comprises the transformation of approximately 15,700 square metres of office space and is expected to welcome its first tenants in late 2025. Arcona has been contributing to Genesta's project, which involves Hornsgatan 122–130, since 2021. In the project’s previous phases,

Communiqué from Bio-Works Technologies’ annual general meeting 2024

Bio-Works Technologies’ annual general meeting was held 24 May 2024. The following resolutions were made at the annual general meeting, among other resolutions.The meeting adopted the income statement and balance sheet and the consolidated income statement and consolidated balance sheet for the financial year 2023. The meeting resolved that no dividend shall be paid for the financial year 2023.The meeting granted the board members and CEO discharge from liability for the financial year 2023.The meeting resolved that the number of board members shall be five and re-elected Peter von

NYAB Oyj - Managers' Transactions

NYAB PlcMANAGERS' TRANSACTIONS24 May 2024 at 10:35NYAB Oyj - Managers' Transactions____________________________________________Person subject to the notification requirementName: Anders BergPosition: Member of the Board/Deputy member Issuer: NYAB OyjLEI: 743700UX7WTIOT3QO547Notification type: INITIAL NOTIFICATIONReference number: 63976/5/4 ____________________________________________Transaction date: 2024-05-23Venue: FIRST NORTH GROWTH MARKET FINLAND (FSME)Instrument type: SHAREISIN: FI4000153515Nature of transaction: ACQUISITION  Transaction details(1):

Fiven ASA - First Quarter Results 2024

· The total revenues in Q1 2024 reached EUR 35.2m, representing a sequential reduction of · -1.4% from Q4-2023 and -13.1% versus Q1 2023. Customized products evidenced resilience vs. current market situation. · The adjusted EBITDA was EUR 10.5m, up from EUR 9.6m in Q4 2023 and compared to EUR 13.0m in Q1 2023, (Q1 2023 being historically the strongest Q1 result of Fiven) · Cash Flow from Operations was EUR -0.1m compared with EUR 2.8m Q1 LY. The lower cash generation in 2024 was impacted by a one-off change in working capital of EUR -2m. · The cash balance ended at EUR 29.1m, a

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 116 – 24 MAY 2024 In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 96/24.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Stig Frederiksen, Head of Communications & Investor Relations, tel.: +45 32 71 08 55, e-mail: sfr@norden.com

BioStock: CLS revises strategy – increases focus on neurosurgery

Clinical Laserthermia Systems revises its strategy to increase the possibility of achieving the goal of reaching a positive cash flow in 2026. The new strategy prioritizes the neurosurgery business area, enabling cost savings of approximately SEK 65 million.– The background to the announced changes to the business is the strength of the ClearPoint Prism product offering, a strength that has become increasingly clear in the spring of 2024 through the initial market launch in the US, CLS writes.Read the full article at biostock.se : https://www.biostock.se/en/

Inside Information: CapMan considers issuance of new sustainability-linked notes and announces a voluntary tender offer of its 2025 notes

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. CapMan PlcStock Exchange Release / Inside information24 May 2024 at 10:15 EEST Inside Information: CapMan considers issuance of new sustainability-linked notes and announces a voluntary tender offer of its 2025 notes CapMan Plc (the "Company") is considering the issuance of new sustainability-

CapMan publishes new Sustainability-Linked Bond Framework, strengthens link to climate targets

CapMan press release24 April 2024 at 10:10 a.m. EEST CapMan publishes new Sustainability-Linked Bond Framework, strengthens link to climate targets CapMan has established a new Sustainability-Linked Bond Framework under which it can issue securities with a sustainability-linkage. The selected KPIs cover over 90% of CapMan's total emissions and as such present a strong linkage to CapMan’s climate work. This new Framework reflects CapMan’s deep commitment to play its part in climate change mitigation. In 2022 CapMan established its first Sustainability-Linked Finance Framework and

Q3 Interim Report January - March 2024

About Hamlet BioPharma   Hamlet BioPharma is an innovative biotechnology company that develops scientific discoveries into drugs for the treatment of cancer and infections. The goal is to address unmet medical needs in large patient groups in need of improved cancer treatments or alternatives to antibiotics. The company is leveraging highly innovative scientific discoveries and an extensive IP portfolio, to take these innovative drugs through mechanistic and preclinical phases, through the development of drug production technology to the clinic. Three projects in clinical development

NOTICE TO ANNUAL GENERAL MEETING IN CHROMOGENICS AB

Shareholders of ChromoGenics AB, reg. no 556630-1809 are hereby summoned to the annual general meeting to be held on 25 June 2024 at 10.00 CEST at Clarion Hotel Gillet on Dragarbrunnsgatan 23 in Uppsala.The registration to the meeting will open at 9.30 CEST. Right to participate and notice of participation A shareholder who wishes to participate at the annual general meeting must: (i) be recorded in the share register maintained by Euroclear Sweden AB on 14 June 2024, and(ii) notify the company of its intention to participate by post to ChromoGenics AB,

Dolphin Drilling - Presentation of first quarter 2024 financial results

(Oslo, 24 May 2024) Dolphin Drilling AS (OSE: DDRIL, Dolphin Drilling) plan to publish its financial report for the first quarter of 2024 on Wednesday 29 May at 07.30 CET. The results will be presented on 29 May 2024 through an audiocast starting 15:00 CET. The presentation will be held by CEO Bjørnar Iversen and CFO Stephen Cox. Link to Q1 audiocast: https://channel.royalcast.com/landingpage/hegnarmedia/20240529_2/ Participants may also visit the Investor Relations section of the Company's website at www.dolphindrilling.com and click on the link to "Webcast". There will be a Q&A

#24-56 TopRight Nordic AB receives observation status

TopRight Nordic AB ("the Company"), whose shares are listed on Nordic SME, disclosed a press release on May 24, 2024, with information that the annual report will not be ready in time for the annual general meeting, which will therefore be postponed until after the summer. According to the Rules for companies whose shares are listed on Nordic SME, a company's shares can be placed under observation if there is material uncertainty about the company’s financial situation. With reference to situation the above, Nordic Growth Market NGM AB has decided to place the shares in the Company

Meliva healthcare center chooses Första Långgatan and Wallenstam

From October, there are completely new opportunities to access healthcare services at the Långgatan streets in Gothenburg. Then Meliva healthcare center and child healthcare center will open a new 710-square-meter unit at Första Långgatan 16.“To help ensure that the local area close to the Långgatan streets is supplemented with both a new healthcare center and child healthcare center feels very positive. We are looking forward to welcoming Meliva to us,” says Marina Fritsche, Regional Director Gothenburg and Vice CEO of Wallenstam. “Masthuggskajen is a really exciting district as you

Epiroc to acquire French manufacturer of excavator attachments

Stockholm, Sweden: Epiroc, a leading productivity and sustainability partner for the mining and construction industries, has agreed to acquire ACB+, a manufacturer of attachments and related couplers used by the construction industry.ACB+ is based in Saint Lager, France, and has several production facilities in the country. It manufactures attachments and quick couplers used on excavators for construction as well as related areas such as scrap recycling and deconstruction. Quick couplers are used with carriers, typically excavators, to enable safe and efficient change of attachments, such

Global Partnerships Pave the Way for a Sustainable Future.

May is a time to celebrate the success of our global partnerships and collaborations within the construction industry. Our network of partners and installers around the world plays a crucial role in delivering innovative and sustainable solutions. This month, we highlight an outstanding project that exemplifies how collaboration can lead to remarkable achievements in the construction field.Successful Partnership One of our most noted collaborations is the VillaZero project with Fiskarhedenvillan, Mondo Architects, and Structor Byggteknik Dalarna, supported by the county of Dalarna. This

The board of directors exercises authorizations to issue and repurchase C-shares, and converts C-shares to common shares

Moberg Pharma AB (publ) today announces that the board of directors exercises authorizations to issue and repurchase C-shares, and converts C-shares to common shares, to secure the company’s commitments under incentive programmes and for the purpose of covering certain costs that may arise as a result of incentive programs.The annual general meeting of Moberg Pharma AB (publ) on 14 May 2024 resolved – for the purpose of ensuring that the company can fulfil its commitments under the long-term incentive programme LTI 2024 resolved by the annual general meeting and for the purpose of covering

HKScan Corporation’s new name HKFoods Plc registered in the Trade Register

HKScan Corporation, Stock Exchange Release 24 May 2024, at 9.30 a.m. EESTThe change decided by the Annual General Meeting of HKScan Corporation on 18 April 2024 has been registered in the Trade Register today, 24 May 2024. The company name has changed to HKFoods Oyj in Finnish, HKFoods Plc in English and HKFoods Abp in Swedish. In connection with the name change, the company’s symbols on the Nasdaq Helsinki trading system will change. The new trading symbol will be HKFOODS. The changes will enter into force on the Nasdaq Helsinki trading system on 27 May 2024. The ISIN code will remain

Cinode Launches Europe-wide Fishing Competition for Consultants and Consultancies

Cinode, a leading platform for consultancies, is excited to announce the launch of the "Catch All the Opportunities" fishing competition. This unique event invites consultants and consultancies across Europe to showcase their fishing skills from May 15th to August 15thThe competition features two categories: Individual Contest, where participants compete to catch the biggest fish, and Company Contest, aiming for the highest total number of fish caught by a consultancy. Participants simply post their catches on LinkedIn, tagging @Cinode and using #catchalltheopportunities. Prizes include:

BioStock: Respiratorius takes another step toward partnering

The in-depth partner discussions have resulted in Respiratorius’ potential partner still being interested in co-financing a phase III study. However, additional financial muscle is needed before a study with VAL001 can be conducted. – We believe that the potential partner’s interest will be an important piece of the puzzle as we continue to work towards an agreement, says CEO Johan Drott.Read the full article at biostock.se : https://www.biostock.se/en/2024/05/respiratorius-takes-another-step-toward-partnering/ This is a press release from BioStock -

No. 49, 2024 – Nordea Kredits drawings as per 1 July 2024

Nordea Kredit hereby announces drawings data for callable covered mortgage credit bonds (SDRO) as per 1 July 2024. The figures are published in order to comply with publication requirements in the transparency regulation 2017/1129/EU and the Danish Act on Capital Markets section 24.   Questions can be directed to Torben Jurlander phone +45 55 47 41 99.     Yours faithfully   Nordea Kredit Realkreditaktieselskab

QuickMIC® installation for clinical routine use in Central Eastern Europe

The diagnostics company Gradientech today announces that Biomedica Medizinprodukte GmbH, its appointed distributor for Austria, Switzerland, and Central Eastern Europe, has acquired its first customer for QuickMIC® in clinical routine use.A university hospital in the Central Eastern Europe market has now started to implement the QuickMIC® system for ultra-rapid antibiotic susceptibility testing (AST) in clinical routine, to use it in their program for hospital-acquired infections. “This is a significant milestone in our partnership together with Gradientech to implement the QuickMIC

Appointment of Non-Executive Director

24 May 2024 Everest Global plc (“Company”) Appointment of Non-Executive Director   The Company announces that Mr Feng Chen (aged 48) has been appointed as a non-executive director of the Company effective as of 1 June 2024. Mr Chen holds an MSc from the University of Reading and is the Chief Executive Director of Precious Link (UK) Limited, the wine retailer in the Southeast of England, that the Company acquired in January 2024. Mr Feng Chen holds 12,500,000 Ordinary Shares in the Company representing approximately 16.2% of the issued share capital of the Company. In

There are no items matching the current filter
There are no more items matching the current filter
Back to top